A number of GPCRs, including OR51E2 and CXCR4 (Taichman et al., 2002; Xu et al., 2006), are over-expressed in prostate cancer patients and regulate prostate cancer cell growth, migration and invasion, and prostate cancer progression. Here, OR51E2 is linked to prostate cancer.